Your next cancer breakthrough could be one study away.

One Focus. One Purpose. Oncology Research.

Pharmacology Expertise | Leading Technology | Data-driven Insight

Solutions To Advance Your Preclinical Oncology Research

MI Bioresearch (MI), formerly Molecular Imaging, Inc., is a preclinical oncology service provider, offering in vitro and in vivo pharmacology services, in vivo imaging technologies, and focal radiation capabilities to support your research programs. Our team helps you explore the effects of drugs and biologics using both human and syngeneic tumor models. MI provides you with decision-driving data to help advance your drug candidate toward the next cancer research breakthrough.

When your research has the potential to save lives, you deserve a partner with the oncology pharmacology knowledge, breadth of tools, and experience to help move life-changing drug candidates through preclinical development quickly and effectively.

Our Services and Solutions



We offer over 30 different syngeneic tumor models, from both solid and disseminated origins, to provide you with many choices to further your immuno-oncology research.

In Vivo Pharmacology

In Vivo Pharmacology

Our scientists will work collaboratively with you to create an approach to help you thoroughly evaluate your drug candidates; then provide you with high quality data to make key decisions about your agent or program.

In Vitro Services

In Vitro Services

We offer a full suite of molecular and cellular biology assays to address the invaluable need for analysis of target and drug activity before, during, and after an in vivo experiment.



We have harnessed the power of in vivo imaging for over a decade, offering services on the widest breadth of state-of-the-art instrumentation available.

Latest NewsView All

Model Spotlight

Upcoming EventsView All


CAR-TCR Summit 2018

September 4-7 | Boston, MA
Booth #67

SITC 2018

November 7-11 | Washington, DC
Booth #230